Jose Saldanha
58Patents
21h-index
73Co-inventors
91Inventor score
Filing activity: Nov 6, 1992 → Jun 16, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5558864A | Humanized and chimeric anti-epidermal growth factor receptor monoclonal antibodies | Emerging Cross-Sectional Technologies | 310 | Expired |
| US5795965A | Reshaped human to human interleukin-6 receptor | Chemistry; Metallurgy | 262 | Expired |
| US7479543B2 | Reshaped human antibody to human interleukin-6 receptor | Chemistry; Metallurgy | 197 | Expired |
| US5817790A | Reshaped human antibody to human interleukin-6 receptor | Chemistry; Metallurgy | 166 | Expired |
| US5840299A | Humanized antibodies against leukocyte adhesion molecule VLA-4 | Chemistry; Metallurgy | 156 | Expired |
| US7256273B2 | Humanized antibodies that recognize beta amyloid peptide | Chemistry; Metallurgy | 107 | Expired |
| US7179892B2 | Humanized antibodies that recognize beta amyloid peptide | Chemistry; Metallurgy | 100 | Expired |
| US7060808B1 | Humanized anti-EGF receptor monoclonal antibody | Chemistry; Metallurgy | 92 | Expired |
| US6455677B1 | FAP&agr;-specific antibody with improved producibility | Chemistry; Metallurgy | 84 | Expired |
| US7189819B2 | Humanized antibodies that recognize beta amyloid peptide | Chemistry; Metallurgy | 72 | Expired |
| US7615213B2 | Antibodies against human interleukin-13 and pharmaceutical compositions thereof | Chemistry; Metallurgy | 63 | Active |
| US8246958B2 | Methods of inhibiting alpha-4-dependent interactions with VCAM-1 with anti-VLA-4 antibodies | Physics | 53 | Active |
| US7147851B1 | Humanized immunoglobulin reactive with α4β7 integrin | Chemistry; Metallurgy | 47 | Expired |
| US7582733B2 | Humanized antibodies that recognize beta amyloid peptide | Chemistry; Metallurgy | 45 | Expired |
| US7700751B2 | Humanized antibodies that recognize β-amyloid peptide | Chemistry; Metallurgy | 31 | Active |
| US7358054B2 | Antibodies to VLA-1 | Emerging Cross-Sectional Technologies | 30 | Expired |
| US7871615B2 | Humanized antibodies that recognize beta amyloid peptide | Chemistry; Metallurgy | 30 | Expired |
| US5800815A | Antibodies to P-selectin and their uses | Chemistry; Metallurgy | 28 | Expired |
| US8128928B2 | Humanized antibodies that recognize beta amyloid peptide | Chemistry; Metallurgy | 26 | Active |
| US8609820B2 | Humanized antibodies that recognize alpha-synuclein | Physics | 24 | Active |
| US6072035A | Reshaped monoclonal antibodies against an immunoglobulin isotype | Chemistry; Metallurgy | 21 | Expired |
| US8790644B2 | Humanized antibodies that recognize alpha-synuclein | Chemistry; Metallurgy | 21 | Active |
| US7928203B2 | Chimeric, humanized, or human antibody 2A4 | Emerging Cross-Sectional Technologies | 20 | Active |
| US5958708A | Reshaped monoclonal antibodies against an immunoglobulin isotype | Chemistry; Metallurgy | 19 | Expired |
| US7943742B2 | Anti-αvβ6 antibodies and uses thereof | Emerging Cross-Sectional Technologies | 17 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.